$132.06▾ 4.99%
End-of-day close · 2026-09-01
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
More coming: dilution / share-count creep.
✦ The read
Twist Bioscience Corporation's earnings-quality signal is not available yet.
Key numbers
Recent news
Sentiment · last 30 days3 articles
3 bullish0 neutral0 bearish
Global Synthetic Antibody Library Market Report 2026: Size and Forecast to 2030 | Capitalize on 12% CAGR and AI Design with Charles River, Twist Bioscience, GenScript and AbCellera
Why Twist Bioscience Stock Skyrocketed This Week
Cathie Wood Is Selling This High-Flying Stock. Is It a Buy?
The Next Wave of Medical AI Could Mint More Millionaires Than the First -- Here Are the Stocks to Own